HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Braunlin, E. A. Articles by Bolman, R. M. Search for Related Content PubMed PubMed Citation Articles by Braunlin, E. A. Articles by Bolman, R. M., 3d

The Annals of Thoracic Surgery, Vol 49, 385-390, Copyright © 1990 by The Society of Thoracic Surgeons

ARTICLES

Rejection and infection after pediatric cardiac transplantation

EA Braunlin, CE Canter, MT Olivari, WS Ring, TL Spray and RM Bolman 3d
Department of Pediatrics, University of Minnesota Hospital and Clinic, Minneapolis.

Cardiac transplantation has only recently become an accepted therapeutic modality for children and adolescents with end-stage cardiomyopathy. Long-term survival, the incidence of rejection, and the incidence of infection are still being defined. From 1985 to 1989, 21 children aged 6 months to 19 years (average age, 11.2 years) underwent cardiac transplantation at our institutions. Eighteen survived the operative period and have been followed for 5 to 49 months (average follow-up, 24 months). All operative survivors have received triple- drug immunosuppression consisting of cyclosporine, azathioprine, and prednisone. During follow-up, 7 patients have been treated on 12 occasions for rejection as documented by endomyocardial biopsy. Eight (67%) of the 12 episodes of rejection occurred in the presence of subtherapeutic cyclosporine levels. Two of the 7 patients treated for rejection have subsequently died of ongoing cardiac rejection and arrhythmia. There have been no perioperative or late deaths from infection. Bacterial sepsis was identified and treated twice during follow-up, viral infections on five occasions, and fungal infection once. Actuarial 1-year survival and 3-year survival of the 18 operative survivors are 94% and 78%, respectively. In the first 7 months after cardiac transplantation, 73% of patients were free from rejection and 83% were free from serious bloodborne infection.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				Y. S. Tjang, U. Blanz, L. Hornik, G. Tenderich, M. Morshuis, H. Stenlund, A. Bairaktaris, and R. Korfer Heart Transplantation in Children: Clinical Outcomes in a Single Center Ann. Thorac. Surg., November 1, 2007; 84(5): 1640 - 1644. [Abstract] [Full Text] [PDF]

				D. A. Fullerton, D. N. Campbell, S. D. Jones, J. Jaggers, J. M. Brown, M. M. Wollmering, F. L. Grover, C. Mashburn, M. Luna, H. M. Sondheimer, et al. Heart Transplantation in Children and Young Adults: Early and Intermediate-Term Results Ann. Thorac. Surg., April 1, 1995; 59(4): 804 - 811. [Abstract] [Full Text]